Cargando…
Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen for coronavirus disease-2019 (COVID-19), which has posed an increasing serious public health threat. However, still there are no approved antiviral agents or vaccines available yet. Mesenchymal stem cells (MSCs) a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674275/ https://www.ncbi.nlm.nih.gov/pubmed/33224928 http://dx.doi.org/10.3389/fbioe.2020.557652 |